Iridex reiterated its financial outlook for 2023, expecting Cyclo G6 probe sales of 65,000 to 67,000 representing approximately 9% to 12% growth over 2022 and to expand the Cyclo G6 systems installed base by 225 to 250 systems. Total revenue for the full year is expected to be $57 million to $59 million. 2023 total revenue guidance represents growth of approximately 3% to 6% after adjusting for an approximate $1.5 million reduction of Other Revenue royalty income resulting from the expiration of licensed patents.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 USD | +2.99% |
|
-3.27% | -26.33% |
21/06 | IRIDEX Corporation Announces Composition of Audit Committee | CI |
24/05 | IRIDEX Corporation Appoints Patrick Mercer as Its President | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.33% | 32.67M | |
+0.91% | 204B | |
+3.74% | 178B | |
+28.89% | 156B | |
+31.66% | 113B | |
+1.18% | 64.26B | |
+19.45% | 54.98B | |
-3.44% | 47.44B | |
-9.28% | 36.7B | |
-0.10% | 34.84B |
- Stock Market
- Equities
- IRIX Stock
- News IRIDEX Corporation
- IRIDEX Corporation Reiterates Financial Guidance for 2023